Literature DB >> 28477850

Clinical features of amyotrophic lateral sclerosis and their prognostic value.

C Tard1, L Defebvre2, C Moreau2, D Devos2, V Danel-Brunaud3.   

Abstract

In classic amyotrophic lateral sclerosis (ALS), the relative degree of impairment of cortical vs spinal motor neurons serving the different body regions is highly variable. This means that an accurate, systematic assessment of the patient's clinical presentation is essential for both the diagnosis and prognosis. The patient's phenotype, rate of disease progression, time of onset (if early) of respiratory failure and nutritional status all have prognostic value, and should be specified in the nosological classification of the disease.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Clinical trial; Motor neuron disease; Progressive muscular atrophy; Pseudopolyneuritic form; Scapuloperoneal syndrome

Mesh:

Year:  2017        PMID: 28477850     DOI: 10.1016/j.neurol.2017.03.029

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  6 in total

Review 1.  Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment.

Authors:  Tereza Filipi; Zuzana Hermanova; Jana Tureckova; Ondrej Vanatko; And Miroslava Anderova
Journal:  J Clin Med       Date:  2020-01-18       Impact factor: 4.241

Review 2.  A Systematic Review of Genotype-Phenotype Correlation across Cohorts Having Causal Mutations of Different Genes in ALS.

Authors:  Owen Connolly; Laura Le Gall; Gavin McCluskey; Colette G Donaghy; William J Duddy; Stephanie Duguez
Journal:  J Pers Med       Date:  2020-06-29

3.  A Novel Variant in Superoxide Dismutase 1 Gene (p.V119M) in Als Patients with Pure Lower Motor Neuron Presentation.

Authors:  Claudia Ricci; Fabio Giannini; Giulia Riolo; Silvia Bocci; Stefania Casali; Stefania Battistini
Journal:  Genes (Basel)       Date:  2021-09-29       Impact factor: 4.096

4.  Histomorphology of Amyotrophic Lateral Sclerosis: An Autopsy Case Report.

Authors:  George S Stoyanov; Deyan L Dzhenkov; Lilyana Petkova
Journal:  Cureus       Date:  2021-05-13

Review 5.  From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline.

Authors:  Rajka Maria Liscic; Antonella Alberici; Nigel John Cairns; Maurizio Romano; Emanuele Buratti
Journal:  Mol Neurodegener       Date:  2020-06-01       Impact factor: 14.195

Review 6.  Organ on a Chip: A Novel in vitro Biomimetic Strategy in Amyotrophic Lateral Sclerosis (ALS) Modeling.

Authors:  Babak Arjmand; Shayesteh Kokabi Hamidpour; Zahra Rabbani; Akram Tayanloo-Beik; Fakher Rahim; Hamid Reza Aghayan; Bagher Larijani
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.